China Covid-19 Vaccine Development Tools Market Size & Outlook
Related Markets
China covid-19 vaccine development tools market highlights
- The China covid-19 vaccine development tools market generated a revenue of USD 2,555.8 million in 2020 and is expected to reach USD 4,077.5 million by 2028.
- The China market is expected to grow at a CAGR of 6% from 2021 to 2028.
- In terms of segment, laboratory technologies was the largest revenue generating technologies in 2020.
- Online Technologies is the most lucrative technologies segment registering the fastest growth during the forecast period.
Covid-19 vaccine development tools market data book summary
| Market revenue in 2020 | USD 2,555.8 million |
| Market revenue in 2028 | USD 4,077.5 million |
| Growth rate | 6% (CAGR from 2020 to 2028) |
| Largest segment | Laboratory technologies |
| Fastest growing segment | Online Technologies |
| Historical data | 2020 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Laboratory Technologies, Online Technologies |
| Key market players worldwide | Thermo Fisher Scientific Inc, Pfizer Inc, Sartorius AG, Stemcell Holdings Inc Ordinary Shares, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Merck KGaA, Qiagen NV, Shimadzu Corp, Eurofins Scientific SE, Charles River Laboratories International Inc, Takara Bio Inc, Olympus Corp, Avantor Inc, Aurora Innovation Inc Class A, Standard BioTools Inc, Celerion, Cole-Parmer, Hartford Schroders International Stk I, Revvity Inc, Fluidigm Corporation, Polyplus-transfection, Hamilton Lane Inc Class A |
Other key industry trends
- In terms of revenue, China accounted for 16.0% of the global covid-19 vaccine development tools market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Asia Pacific, China covid-19 vaccine development tools market is projected to lead the regional market in terms of revenue in 2028.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 955.5 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
COVID-19 Vaccine Development Tools Market Scope
COVID-19 Vaccine Development Tools Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Hamilton Lane Inc Class A | View profile | 600 | 110 Washington Street, Suite 1300, Conshohocken, PA, United States, 19428 | https://www.hamiltonlane.com |
| Polyplus-transfection | View profile | 11-50 | Illkirch-graffenstaden, Alsace, France, Europe | http://www.polyplus-transfection.com |
| Fluidigm Corporation | View profile | 501-1000 | South San Francisco, California, United States, North America | https://www.fluidigm.com |
| Revvity Inc | View profile | 11500 | 940 Winter Street, Waltham, MA, United States, 02451 | https://www.revvity.com |
| Hartford Schroders International Stk I | View profile | - | - | - |
| Cole-Parmer | View profile | - | Vernon Hills, Illinois, United States, North America | https://www.coleparmer.com/ |
| Celerion | View profile | 1001-5000 | Lincoln, Nebraska, United States, North America | https://celerion.com/ |
| Standard BioTools Inc | View profile | 539 | 2 Tower Place, Suite 2000, South San Francisco, CA, United States, 94080 | https://www.standardbio.com |
| Aurora Innovation Inc Class A | View profile | 1800 | 1654 Smallman Street, Pittsburgh, PA, United States, 15222 | https://www.aurora.tech |
| Avantor Inc | View profile | 14500 | 100 Matsonford Road, Suite 200, Building One, Radnor Corporate Center, Radnor, PA, United States, 19087 | https://www.avantorsciences.com |
| Takara Bio Inc | View profile | 1793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | http://www.takara-bio.co.jp |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Stemcell Holdings Inc Ordinary Shares | View profile | - | 1185 Avenue of the Americas, 3rd Floor, New York, NY, United States, 10036 | https://www.stemcell-holdings.com |
| Sartorius AG | View profile | 14338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | https://www.sartorius.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Shimadzu Corp | View profile | 15284 | 1, Nishinokyo-Kuwabara-cho, Nakagyo-ku, Kyoto, Japan, 604-8511 | http://www.shimadzu.com |
| Olympus Corp | View profile | 33629 | Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, Japan, 163-0914 | http://www.olympus.co.jp |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
China covid-19 vaccine development tools market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 vaccine development tools market will help companies and investors design strategic landscapes.
Laboratory technologies was the largest segment with a revenue share of 95.46% in 2020. Horizon Databook has segmented the China covid-19 vaccine development tools market based on laboratory technologies, online technologies covering the revenue growth of each sub-segment from 2020 to 2028.
China is anticipated to be the largest market for COVID-19 vaccine development tools and in 2021, it was valued at USD 2,555.79 million. Various initiatives are being undertaken by domestic companies to develop and commercialize COVID-19 vaccine, which is expected to drive the market growth.
However, high government intervention in development of the COVID-19 vaccine and absence of independent regulatory institutions restrained growth rate in the country. For instance, China denied the use of most effective and popular vaccine technology, mRNA, and employed traditional, inactivated vaccines to accomplish its 86.6% fully vaccinated rate.
However, as per healthcare professionals in the region, inactivated vaccines are ineffective against the new variants. In January 2022, Walvax Biotech, a Chinese pharmaceutical company, published the clinical data of Phase 1 on China’s first in-house mRNA-based vaccine and proved its effectiveness in inducing an immune response.
Reasons to subscribe to China covid-19 vaccine development tools market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China covid-19 vaccine development tools market databook
-
Our clientele includes a mix of covid-19 vaccine development tools market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China covid-19 vaccine development tools market , including forecasts for subscribers. This country databook contains high-level insights into China covid-19 vaccine development tools market from 2020 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
China covid-19 vaccine development tools market size, by online technologies, 2020-2028 (US$M)
China COVID-19 Vaccine Development Tools Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
